CN101966312B - Chinese medicinal composition for treating chronic renal failure and preparation method thereof - Google Patents
Chinese medicinal composition for treating chronic renal failure and preparation method thereof Download PDFInfo
- Publication number
- CN101966312B CN101966312B CN2009102181373A CN200910218137A CN101966312B CN 101966312 B CN101966312 B CN 101966312B CN 2009102181373 A CN2009102181373 A CN 2009102181373A CN 200910218137 A CN200910218137 A CN 200910218137A CN 101966312 B CN101966312 B CN 101966312B
- Authority
- CN
- China
- Prior art keywords
- fructus
- percent
- renal failure
- chronic renal
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal composition for treating chronic renal failure and a preparation method thereof. According to the formula of a monarch medicament, a ministerial medicament, an adjuvant medicament and a conductant medicament, the composition comprises the following components in percentage by weight: 11 to 12 percent of Chinese cinnamon and 8 to 9 percent of longan flesh which serve as the monarch medicament, 16 to 17 percent of astragals, 8 to 9 percent of danshen root, 8 to 9 percent of peach seeds and 8 to 9 percent of coix seeds which serve as the ministerial medicament, and 11 to 12 percent of fennel, 8 to 9 percent of costustoot, 8 to 9 percent of szechwan China berry fruit and 1 to 12 percent of dark plum fruit which serve as the adjuvant medicament and the conductant medicament. The Chinese medicinal composition for treating chronic renal failure can be prepared into any solid formulation, including capsules, tablets, pulvis or pills and the like by the traditional Chinese medicine preparation technique and technical method. The Chinese medicinal composition of the invention has the effect of releasing symptoms of mice with chronic renal failure caused by adenine and reducing serum creatinine, urea nitrogen and urine protein within 24 hours.
Description
Technical field
The invention belongs to the field of Chinese medicines, relate to a kind of method for preparing of treating the Chinese medicine composition of chronic renal failure.
Background technology
(chronic renal failure CRF) is meant the clinical syndrome that the deterioration of carrying out property of chronic kidney damage is occurred due to a variety of causes a series of symptoms or metabolism disorder are formed, and is the end stage eventually of chronic renal disease in chronic renal failure.CRF is common clinical, frequently-occurring disease, and the state of an illness is critical, serious harm patient's health even life.According to statistics, there is 1 people that chronic renal failure (calling " renal failure " in the following text) takes place approximately in annual per 10,000 populations of China
[1], therefore, renal failure is to influence one of serious disease of China's people's health.At present, the state-of-the-art method of treatment chronic renal failure is dialysis and renal transplantation (kidney alternative medicine).But because of economy and medical condition are limit, China patient that can accept dialysis therapy every year only accounts for 10% so far
[2], China successfully carries out renal transplantation to come 2002, and renal transplantation is totally 40393 examples, according to bibliographical information
[3], 1 annual survival rate of transplanted kidney is that 85%, 5 annual survival rate is about 60%.The characteristics of chronic renal failure are that the course of disease is longer, and are intricate, and mostly deficiency in origin and excess in superficiality is treating both the principal and the secondary aspects of a disease at the same time in the treatment, have biased again.Common method comprises that mainly kidney and spleen invigorating, function of spleen and stomach regulating, blood circulation promoting and blood stasis dispelling, purging FU-organs rush down turbid, eliminating damp-heat etc.
[4]
Because China is flourishing inadequately economically, populous, especially rural population is numerous, and the patient that chronic renal failure takes place is also most of in the rural area, even if in the city, and the also most financial burden that can not bear the kidney alternative medicine of average family.With the traditional Chinese medical science is main, the therapy of combining Chinese and Western medicine renal failure, though be a kind of traditional treatment, because of convenient, effective, cheapness is taken like a shot patient, therefore, for the patient of vast rural area and financial difficulties, still has wide range of therapeutic prospect and practical value.(list of references [1] Ye Rengao. internal medicine [M]. the 5th edition. Beijing: People's Health Publisher; 2000.569. [2] Guan Guangju. newly organized nephrology [M]. Jinan: Shandong science tech publishing house, 2001.321. [3] Ye Rengao. internal medicine [M]. the 4th edition. Beijing: People's Health Publisher, 1998.511. [4] Guo Yancong; Yang Yanfang; Li Ping. the Chinese medicine of chronic renal failure [J]. Chinese combination of Chinese and Western medicine nephropathy magazine, 2003,4 (3): 178～179.)
Summary of the invention
In order to solve the problem that prior art exists, the invention provides a kind of method for preparing of treating the Chinese medicine composition of chronic renal failure.
The composition and the weight proportion of the Chinese medicine composition of described treatment chronic renal failure are following:
According to monarch, minister, help, make and carry out prescription: Cortex Cinnamomi, Fructus Alpiniae Oxyphyllae are monarch drug; Semen Persicae, Semen Coicis, Radix Salviae Miltiorrhizae, the Radix Astragali are ministerial drug; The Radix Aucklandiae, Fructus Toosendan, Fructus Mume, Fructus Foeniculi are adjuvant altogether; Cortex Cinnamomi 11%～12%, Fructus Alpiniae Oxyphyllae 8%～9%, the Radix Astragali 16%～17%, Radix Salviae Miltiorrhizae 8%～9%, Semen Persicae 8%～9%, Semen Coicis 8%～9%, Fructus Foeniculi 11%～12%, the Radix Aucklandiae 8%～9%, Fructus Toosendan 8%～9%, Fructus Mume 11%～12%.
The optimum weight proportioning of Chinese medicine composition of the present invention is: Cortex Cinnamomi 11.11%, Fructus Alpiniae Oxyphyllae 8.33%, the Radix Astragali 16.67%, Radix Salviae Miltiorrhizae 8.33%, Semen Persicae 8.33%, Semen Coicis 8.33%, Fructus Foeniculi 11.12%, the Radix Aucklandiae 8.33%, Fructus Toosendan 8.33%, Fructus Mume 11.12%.
Below, according to tcm theory, a kind of prescription of treating the Chinese medicine composition of chronic renal failure of the present invention is further explained:
Cortex Cinnamomi is hot, sweet in the side, big heat.Return kidney, spleen, the heart, Liver Channel.It is supporing yang to mend fire, let the fire back to its origin, dispersing cold for relieving pain, promoting blood circulation to restore menstrual flow.Fructus Alpiniae Oxyphyllae acrid in the mouth, warm in nature is returned spleen, kidney channel.Have warming spleen and stopping diarrhaly, take the photograph saliva, warming the kidney, the effect of controlling nocturnal emission with astringent drugs reducing urination.Two medicines mutually 5 can kidney-replenishing, can make lower-jiao Qi dysfunction especially, and can go into spleen temperature soil, helps spleen positive, admittedly protect kidney-Yang, so be monarch drug.Radix Astragali sweet in the mouth, slightly warm in nature in the side.Return lung, spleen channel.Has invigorating QI to consolidate the body surface resistance, diuresis, expelling pus and toxin by strengthening QI, functions such as granulation promoting.The Semen Coicis slightly sweet flavor, cold nature is returned spleen, stomach, lung meridian.The spleen invigorating eliminating dampness by diuresis, eliminating impediment antidiarrheal, clearing away heat and discharging pus.Two medicines and monarch drug share the master and go into spleen channel, to insufficiency of the spleen all diseases, distinguished service are arranged especially.To edema due to deficiency of the spleen, dysuria has QI invigorating and diuresis economic benefits and social benefits concurrently, closes in monarch drug, can fill Yuanyang, sharp life.Be equipped with Radix Salviae Miltiorrhizae, Semen Persicae, blood stasis dispelling swings long-pending, and then blood stasis is dispelled, and fresh blood is given birth to, and has much the wonderful of qi and blood tonifying.So four Chinese medicine is ministerial drug altogether.Fructus Toosendan is bitter, and is cold; Slightly poisonous.Return liver, small intestinal, urinary bladder channel.Has soothing liver-QI, promoting the circulation of QI to relieve pain, effects such as anthelmintic.The Fructus Foeniculi acrid in the mouth, warm in nature.Return liver,kidney,spleen, stomach warp.Has dispersing cold for relieving pain, the function of regulating qi-flowing for harmonizing stomach.The Radix Aucklandiae is hot, bitter, temperature.Return spleen, stomach, large intestine, three warmers, gallbladder meridian.Effect with promoting the circulation of QI to relieve pain, invigorating the spleen and regulating the stomach.Three flavor medicines all have promoting the circulation of QI to relieve pain, the liver soothing and the spleen invigorating effect, and it is capable to play the capable then blood of gas, the effect of blood circulation promoting and blood stasis dispelling toxin expelling.Fructus Mume sour in the mouth, puckery, warm in nature.Return liver, spleen, lung, large intestine channel.The effect of have astringing the lung, promoting the production of body fluid.Can replenish the loss of body fluid, four Chinese medicine is adjuvant altogether in the side.Last ten flavor medicines phases 5 embody the temperature compensation Liver and kidney, blood stasis dispelling dampness removing effect.
According to composition and percentage by weight proportioning, get Cortex Cinnamomi, the Radix Aucklandiae, Fructus Alpiniae Oxyphyllae and Fructus Foeniculi four flavor Chinese crude drugs, add the water logging bubble 1～3 hour of volume mL of 8～10 times of amounts that are their gross weight g numerical value again, steam distillation extracted volatile oil in 4～6 hours; Filter, get medicinal residues 1 and filtrate 1, subsequent use; Volatile oil drops in the beta-schardinger dextrin-solution with the anhydrous alcohol solution of equal volume amounts, the volume mL of the water of beta-schardinger dextrin-solution: beta-schardinger dextrin-weight g is 10: 1～20: 1; The volume mL of volatile oil: beta-schardinger dextrin-weight g is 1: 4～1: 8, and 40～60 ℃ were stirred 2～4 hours down, 4 ℃ of following cold preservation 24 hours; Sucking filtration; Precipitate gets volatile oil clathrate compound 40 ℃ of oven dry down, and is subsequent use;
According to composition and percentage by weight proportioning; Get the Radix Astragali, Radix Salviae Miltiorrhizae, Semen Persicae, Fructus Mume, Fructus Toosendan and Semen Coicis, add 6～10 times of ethanol waters of measuring volume mL of their gross weight g numerical value again, its volumetric concentration is 50%～90%; Reflux, extract, 1～3 time; Each 1～2 hour, filter, it is subsequent use to get medicinal residues 2; Filtrating merges, and is evaporated to the thick paste of relative density 1.30～1.35 under 50 ℃, and 50 ℃ of following drying under reduced pressure are pulverized, fine powder 1;
Medicinal residues 1 and medicinal residues 2 are merged, add the water extraction 1～3 time of 8～12 times of amount volume mL of total medical material weight g numerical value, each 0.5～1.5 hour, filter, merging filtrate must filtrate 2;
Filtrating 2 merges with filtrating 1, and being evaporated to the quality of liquid medicine volume ratio is 1: 2～1: 8 o'clock, and adding mass and size concentration down at 25～70 ℃ is 2%～8% ZTC-II natural clarifying agent; The ZTC-II natural clarifying agent is purchased positive day one-tenth clarification technique company limited in Beijing, and placement is spent the night, and filters; Filtrating is evaporated to the thick paste of relative density 1.30～1.35 under 50 ℃; 50 ℃ of following drying under reduced pressure are pulverized, and get fine powder 2;
With fine powder 1 and fine powder 2 mix homogeneously, the use volumetric concentration is 80% alcohol granulation, drying, and granulate adds volatile oil clathrate compound, and mix homogeneously gets Chinese medicine composition of the present invention.
A kind of Chinese medicine composition of treating chronic renal failure of the present invention's preparation can be processed any solid dosage forms with existing Chinese drug preparation technique and process, comprises capsule, tablet, powder or pill etc.
In order to understand the therapeutic effect of Chinese medicine composition of the present invention, in 60 rats, do the animal experiment with a kind of Chinese medicine composition of treating chronic renal failure, experimental technique is following:
1, laboratory animal: 60 of male wistar rats, body weight 250 ± 20 grams are provided by Jilin University's Experimental Animal Center.
Experiment medicine: embodiment 4 obtains a kind of Chinese medicine composition of treating chronic renal failure; Use the hot water dissolving; Process every mL respectively and contain a kind of Chinese medicine composition 1.2g, 2.4g and 4.8g that treats chronic renal failure of the present invention, respectively basic, normal, high group is given drug solns.Adenine is provided by chemical reagents corporation of traditional Chinese medicines group, the adenine feedstuff: in normal diet, add adenine, fully mixing is processed solid feed, is provided by Jilin University's Experimental Animal Center, and NIAODUQING KELI is provided by Kangchen Pharmaceutical Co., Ltd., Guangzhou.
Experiment reagent: hematuria creatinine, blood urea nitrogen and urine protein quantitation test kit build up bio-engineering research by Nanjing and provide.
Divide into groups and modeling: 60 rats are divided into 10 of normal group at random, 50 of modeling groups.Modeling group rat is given above-mentioned adenine feedstuff, gives adenine 300mg/kg by body weight, and normal group is given normal diet.Modeling 15 days finishes a few days ago in experiment, and rat is placed metabolic cage, and water is can't help in fasting, collects urine, measures the urine amount, UCr, blood urea nitrogen, urine protein.
3, treatment
With the modeling component is model group, a kind of basic, normal, high dose groups of Chinese medicine composition and positive controls of treating chronic renal failure of the present invention; The dosage of basic, normal, high dose groups; Irritate stomach for drug solns 0.5ml/100g body weight for basic, normal, high group for respectively a kind of Chinese medicine composition of treating chronic renal failure of the present invention; Once a day, positive controls is with NIAODUQING KELI 0.27g/100g body weight rat oral gavage, once a day.6 weeks of successive administration finish a few days ago in experiment, and rat is placed metabolic cage, and water is can't help in fasting, collect urine, detect index of correlation.Put to death rat in one hour after the last administration, get blood and carry out the biochemical indicator detection, get kidney simultaneously, carry out pathology section examination.
4, observation index
Detect: UCr (Cr), blood urea nitrogen (BUN), 24h urine protein quantitation
5, renal tissue changes
1) kidney outward appearance
Normal group: kidney is brown, and quality is solid glossy.
Model group: the obvious swelling of kidney, quality is soft, is canescence, lacks gloss, and peplos etc. are prone to peel off.NIAODUQING KELI group and Chinese medicine composition group: the kidney enlargement, volume increases, and becomes taupe, and quality is more solid, and is slightly glossy.
2) the pathological section mirror is observed down
Normal group: the nephridial tissue structure is no abnormal.Glomerule shows not congested, and renal cells is normal, does not see the yellowish-brown crystallization deposition in the renal tubules, and matter is not had hyperemia, oozes out between renal tubules.
Model group: the kidney pathological change relates to matter between glomerule, renal tubules and kidney, mainly is matter between renal tubules and kidney.Intralesional part renal tubules destroys, and atresia has cell infiltration and proliferation of fibrous tissue in the matter, lymph follicle shape structure is arranged.Visible many yellowish-brown adenine metabolite crystallization depositions in a renal tubules and the matter have foreign body granuloma to form around the crystallization, part tubular ectasia, wherein visible albumen and granular cast.
The Chinese medicine composition group: the nephridial tissue pathological changes is consistent with model group.But pathological changes alleviates than model group, and cell infiltration and proliferation of fibrous tissue area are little than model group; The renal tubules and the intraparenchymatous crystalline solid of kidney that enlarge are also less.Middle dosage Chinese medicine composition administration group nephridial tissue pathological changes is smaller.The part nephridial tissue is more similar with the normal control group.
Positive controls: the nephridial tissue pathological changes is consistent with model group.But pathological changes has than model group and alleviates nephron atrophy, disappearance, the less and most cortex parts that are confined to nearly tunicle of cell infiltration and proliferation of fibrous tissue area; The part nephridial tissue is more similar with the normal control group.
The result shows: can reduce rat serum BUN, Cr, reduce urine protein.
Beneficial effect: the invention provides a kind of method for preparing of treating the Chinese medicine composition of chronic renal failure.The present invention is through pilot scale practice, the dosage form of this kind, dosage, preparation technology etc. done careful discussion, and carried out a series of research work such as quality standard, production technology, obtained satisfied effect.A kind of Chinese medicine composition of treating chronic renal failure of the present invention's preparation can be processed any solid dosage forms with existing Chinese drug preparation technique and process, comprises capsule, tablet, powder or pill etc.The Chinese medicine composition that the present invention preparation a kind of treats chronic renal failure has mitigation to CRF symptom of rats due to the adenine, and has reduction serum creatinine (Cr), blood urea nitrogen (BUN) and the proteic effect of twenty-four-hour urine.The present invention preparation a kind of treats that the dosed administration group contrasts with model group in the Chinese medicine composition of chronic renal failure, and blood urea nitrogen and urine protein all have utmost point significant difference.The numerical value of UCr and blood urea nitrogen sees table 1 for details all less than positive controls.
Table 1 Chinese medicine composition of the present invention is to CRP rat BUN, Cr due to the adenine, and the influence of urine protein level (X ± S)
Annotate: compare with normal group
*P＜0.05,
*P＜0.01,
* *P＜0.001; Compare with model group
△P＜0.05,
△ △P＜0.01,
△ △ △P＜0.001
Description of drawings
The kidney pathology slice map of Fig. 1 normal group.
The kidney pathology slice map of Fig. 2 model group.
The kidney pathology slice map of Fig. 3 Chinese medicine composition group.
The kidney pathology slice map of Fig. 4 positive controls.
The specific embodiment
Embodiment 1
A kind of preparation of treating the Chinese medicine composition of chronic renal failure: according to composition and percentage by weight proportioning, get Cortex Cinnamomi 1920g, Radix Aucklandiae 1440g, Fructus Alpiniae Oxyphyllae 1440g, Fructus Foeniculi 1920g four flavor Chinese crude drugs, the water logging that adds their 8 times of amounts of weight g numerical value volume was again steeped 1 hour; Steam distillation 5 hours extracts volatile oil, filters medicinal residues 1 and filtrate 1 subsequent use; Volatile oil is with the anhydrous alcohol solution of equal volume amounts; Drop in the beta-schardinger dextrin-solution volume mL of the water of beta-schardinger dextrin-solution: beta-schardinger dextrin-weight g is 10: 1, the volume mL of volatile oil: beta-schardinger dextrin-weight g is 1: 4; 40 ℃ were stirred 2 hours down; 4 ℃ of following cold preservation 24 hours, sucking filtration, precipitate are dried to such an extent that volatile oil clathrate compound is subsequent use under 40 ℃;
According to composition and percentage by weight proportioning, get Radix Astragali 2880g, Radix Salviae Miltiorrhizae 1440g, Semen Persicae 1440g, Fructus Mume 1920g, Fructus Toosendan 1440g, Semen Coicis 1440g, add their 12 times of amounts of weight g numerical value volume of ethanol aqueous solution again; Its volumetric concentration is 70% reflux, extract, 2 times, each 1 hour, filters; Medicinal residues 2 are subsequent use, and filtrating merges, and are evaporated to the thick paste of relative density 1.30 under 50 ℃; 50 ℃ of following drying under reduced pressure are pulverized, and get fine powder 1.Medicinal residues 1 and medicinal residues 2 are merged, add the water extraction 0.5 time of 8 times of amount volume mL of total medical material weight g numerical value, each 1 hour; Filter, merging filtrate must filtrate 2; Filtrating 2 merges with filtrating 1, and being evaporated to the quality of liquid medicine volume ratio is 1: 2 o'clock, and adding mass and size concentration is 2% the ZTC-II natural clarifying agent that became the clarification technique company limited in Beijing in positive day of purchasing under 25 ℃ of conditions; Placement is spent the night, and filters, and filtrating is evaporated to the thick paste of relative density 1.30 under 50 ℃; 50 ℃ of following drying under reduced pressure are pulverized, and get fine powder 2.With fine powder 1 and fine powder 2 mix homogeneously, the use volumetric concentration is 80% alcohol granulation, drying, and granulate adds volatile oil clathrate compound, and mix homogeneously is processed certain solid dosage forms, obtains a kind of Chinese medicine composition of treating chronic renal failure.
Embodiment 2:
A kind of preparation of treating the Chinese medicine composition of chronic renal failure: according to composition and percentage by weight proportioning, get Cortex Cinnamomi 2000g, Radix Aucklandiae 1500g, Fructus Alpiniae Oxyphyllae 1500g, Fructus Foeniculi 2000g four flavor Chinese crude drugs, the water logging that adds their 6 times of amounts of weight g numerical value volume was again steeped 2 hours; Steam distillation 6 hours extracts volatile oil, filters medicinal residues 1 and filtrate 1 subsequent use; Volatile oil is with the anhydrous alcohol solution of equal volume amounts; Drop in the beta-schardinger dextrin-solution volume mL of the water of beta-schardinger dextrin-solution: beta-schardinger dextrin-weight g is 15: 1, the volume mL of volatile oil: beta-schardinger dextrin-weight g is 1: 6; 40 ℃ were stirred 4 hours down; 4 ℃ of following cold preservation 24 hours, sucking filtration, precipitate is dried to such an extent that volatile oil clathrate compound is subsequent use at 40 ℃;
According to composition and percentage by weight proportioning, get Radix Astragali 3000g, Radix Salviae Miltiorrhizae 1500g, Semen Persicae 1500g, Fructus Mume 2000g, Fructus Toosendan 1500g, Semen Coicis 1500g, add their 10 times of amounts of weight g numerical value volume of ethanol aqueous solution again; Its volumetric concentration is 70% reflux, extract, 2 times, each 1 hour, filters; Medicinal residues 2 are subsequent use, and filtrating merges, and are evaporated to the thick paste of relative density 1.35 under 50 ℃; 50 ℃ of following drying under reduced pressure are pulverized, and get fine powder 1.Medicinal residues 1 and medicinal residues 2 are merged, add the water extraction 2 times of 8 times of amount volume mL of total medical material weight g numerical value, each 1 hour; Filter, merging filtrate must filtrate 2; Filtrating 2 merges with filtrating 1, and being evaporated to the quality of liquid medicine volume ratio is 1: 8 o'clock, and adding mass and size concentration is 5% the ZTC-II natural clarifying agent that became the clarification technique company limited in Beijing in positive day of purchasing under 50 ℃ of conditions; Placement is spent the night, and filters, and filtrating is evaporated to the thick paste of relative density 1.31 under 50 ℃; 50 ℃ of following drying under reduced pressure are pulverized, and get fine powder 2.With fine powder 1 and fine powder 2 mix homogeneously, the use volumetric concentration is 80% alcohol granulation, drying, and granulate adds volatile oil clathrate compound, and mix homogeneously is processed certain solid dosage forms, obtains a kind of Chinese medicine composition of treating chronic renal failure.
Embodiment 3:
A kind of preparation of treating the Chinese medicine composition of chronic renal failure: according to composition and percentage by weight proportioning, get the water loggings bubble 3 hours that Cortex Cinnamomi 2160g, Radix Aucklandiae 1620g, Fructus Alpiniae Oxyphyllae 1620g, Fructus Foeniculi 2160g four flavor Chinese crude drugs add their 10 times of amounts of weight g numerical value volume again, steam distillation extracted volatile oil in 4 hours; Filter; Medicinal residues 1 and filtrate 1 subsequent usely, volatile oil drops in the beta-schardinger dextrin-solution with the anhydrous alcohol solution of equal volume amounts; The volume mL of the water of beta-schardinger dextrin-solution: beta-schardinger dextrin-weight g is 20: 1; The volume mL of volatile oil: beta-schardinger dextrin-weight g is 1: 6, and 60 ℃ were stirred 2 hours down, 4 ℃ of following cold preservation 24 hours; Sucking filtration, precipitate are dried to such an extent that volatile oil clathrate compound is subsequent use under 40 ℃;
According to composition and percentage by weight proportioning, get Radix Astragali 3060g, Radix Salviae Miltiorrhizae 1620g, Semen Persicae 1620g, Fructus Mume 2160g, Fructus Toosendan 1620g, Semen Coicis 1620g, add their 10 times of amounts of weight g numerical value volume of ethanol aqueous solution again; Its volumetric concentration is 70% reflux, extract, 1 time, each 2 hours, filters; Medicinal residues 2 are subsequent use, and filtrating merges, and are evaporated to the thick paste of relative density 1.31 under 50 ℃; 50 ℃ of following drying under reduced pressure are pulverized, and get fine powder 1.Medicinal residues 1 and medicinal residues 2 are merged, add the water extraction 1 time of 10 times of amount volume mL of total medical material weight g numerical value, each 1.5 hours; Filter, merging filtrate must filtrate 2; Filtrating 2 merges with filtrating 1, and being evaporated to the quality of liquid medicine volume ratio is 1: 5 o'clock, and adding mass and size concentration is 8% the ZTC-II natural clarifying agent that became the clarification technique company limited in Beijing in positive day of purchasing under 70 ℃ of conditions; Placement is spent the night, and filters, and filtrating is evaporated to the thick paste of relative density 1.30～1.35 under 50 ℃; 50 ℃ of following drying under reduced pressure are pulverized, and get fine powder 2.With fine powder 1 and fine powder 2 mix homogeneously, the use volumetric concentration is 80% alcohol granulation, drying, and granulate adds volatile oil clathrate compound, and mix homogeneously is processed certain solid dosage forms, obtains a kind of Chinese medicine composition of treating chronic renal failure.
Embodiment 4:
A kind of preparation of treating the Chinese medicine composition of chronic renal failure: according to composition and percentage by weight proportioning, get the water loggings bubble 1 hour that Cortex Cinnamomi 2400g, Radix Aucklandiae 1800g, Fructus Alpiniae Oxyphyllae 1800g, Fructus Foeniculi 2400g four flavor Chinese crude drugs add their 8 times of amounts of weight g numerical value volume again, steam distillation extracted volatile oil in 4 hours; Filter; Medicinal residues 1 and filtrate 1 subsequent usely, volatile oil drops in the beta-schardinger dextrin-solution with the anhydrous alcohol solution of equal volume amounts; The volume mL of the water of beta-schardinger dextrin-solution: beta-schardinger dextrin-weight g is 10: 1; The volume mL of volatile oil: beta-schardinger dextrin-weight g is 1: 8, and 50 ℃ were stirred 3 hours down, 4 ℃ of following cold preservation 24 hours; Sucking filtration, precipitate are dried to such an extent that volatile oil clathrate compound is subsequent use under 40 ℃;
According to composition and percentage by weight proportioning, get Radix Astragali 3600g, Radix Salviae Miltiorrhizae 1800g, Semen Persicae 1800g, Fructus Mume 2400g, Fructus Toosendan 1800g, Semen Coicis 1800g, add their 8 times of amounts of weight g numerical value volume of ethanol aqueous solution again; Its volumetric concentration is 50% reflux, extract, 3 times, each 1.5 hours, filters; Medicinal residues 2 are subsequent use, and filtrating merges, and are evaporated to the thick paste of relative density 1.32 under 50 ℃; 50 ℃ of following drying under reduced pressure are pulverized, and get fine powder 1.Medicinal residues 1 and medicinal residues 2 are merged, add the water extraction 3 times of 12 times of amount volume mL of total medical material weight g numerical value, each 0.5 hour; Filter, merging filtrate must filtrate 2; Filtrating 2 merges with filtrating 1, and being evaporated to the quality of liquid medicine volume ratio is 1: 2 o'clock, and adding mass and size concentration is 2% the ZTC-II natural clarifying agent that became the clarification technique company limited in Beijing in positive day of purchasing under 50 ℃ of conditions; Placement is spent the night, and filters, and filtrating is evaporated to the thick paste of relative density 1.35 under 50 ℃; 50 ℃ of following drying under reduced pressure are pulverized, and get fine powder 2.With fine powder 1 and fine powder 2 mix homogeneously, the use volumetric concentration is 80% alcohol granulation, drying, and granulate adds volatile oil clathrate compound, and mix homogeneously is processed certain solid dosage forms, obtains a kind of Chinese medicine composition of treating chronic renal failure.
Claims (2)
1. method for preparing of treating the Chinese medicine composition of chronic renal failure is characterized in that step and condition are following:
The composition and the weight proportion of described Chinese medicine composition are following:
According to monarch, minister, help, make and carry out prescription: Cortex Cinnamomi, Fructus Alpiniae Oxyphyllae are monarch drug; Semen Persicae, Semen Coicis, Radix Salviae Miltiorrhizae, the Radix Astragali are ministerial drug; The Radix Aucklandiae, Fructus Toosendan, Fructus Mume, Fructus Foeniculi are adjuvant altogether; Cortex Cinnamomi 11%～12%, Fructus Alpiniae Oxyphyllae 8%～9%, the Radix Astragali 16%～17%, Radix Salviae Miltiorrhizae 8%～9%, Semen Persicae 8%～9%, Semen Coicis 8%～9%, Fructus Foeniculi 11%～12%, the Radix Aucklandiae 8%～9%, Fructus Toosendan 8%～9%, Fructus Mume 11%～12%;
According to composition and percentage by weight proportioning, get Cortex Cinnamomi, the Radix Aucklandiae, Fructus Alpiniae Oxyphyllae and Fructus Foeniculi four flavor Chinese crude drugs, add the water logging bubble 1～3 hour of volume mL of 8～10 times of amounts that are their gross weight g numerical value again, steam distillation extracted volatile oil in 4～6 hours; Filter, get medicinal residues 1 and filtrate 1, subsequent use; Volatile oil drops in the beta-schardinger dextrin-solution with the anhydrous alcohol solution of equal volume amounts, the volume mL of the water of beta-schardinger dextrin-solution: beta-schardinger dextrin-weight g is 10: 1～20: 1; The volume mL of volatile oil: beta-schardinger dextrin-weight g is 1: 4～1: 8, and 40～60 ℃ were stirred 2～4 hours down, 4 ℃ of following cold preservation 24 hours; Sucking filtration; Precipitate gets volatile oil clathrate compound 40 ℃ of oven dry down, and is subsequent use;
According to composition and percentage by weight proportioning; Get the Radix Astragali, Radix Salviae Miltiorrhizae, Semen Persicae, Fructus Mume, Fructus Toosendan and Semen Coicis, add 6～10 times of ethanol waters of measuring volume mL of their gross weight g numerical value again, its volumetric concentration is 50%～90%; Reflux, extract, 1～3 time; Each 1～2 hour, filter, it is subsequent use to get medicinal residues 2; Filtrating merges, and is evaporated to the thick paste of relative density 1.30～1.35 under 50 ℃, and 50 ℃ of following drying under reduced pressure are pulverized, fine powder 1;
Medicinal residues 1 and medicinal residues 2 are merged, add the water extraction 1～3 time of 8～12 times of amount volume mL of total medical material weight g numerical value, each 0.5～1.5 hour, filter, merging filtrate must filtrate 2;
Filtrating 2 merges with filtrating 1, and being evaporated to the quality of liquid medicine volume ratio is 1: 2～1: 8 o'clock, and adding mass and size concentration down at 25～70 ℃ is 2%～8% ZTC-II natural clarifying agent; The ZTC-II natural clarifying agent is purchased positive day one-tenth clarification technique company limited in Beijing, and placement is spent the night, and filters; Filtrating is evaporated to the thick paste of relative density 1.30～1.35 under 50 ℃; 50 ℃ of following drying under reduced pressure are pulverized, and get fine powder 2;
With fine powder 1 and fine powder 2 mix homogeneously, the use volumetric concentration is 80% alcohol granulation, drying, and granulate adds volatile oil clathrate compound, and mix homogeneously obtains a kind of Chinese medicine composition of treating chronic renal failure.
2. a kind of method for preparing of treating the Chinese medicine composition of chronic renal failure as claimed in claim 1 is characterized in that, the composition and the weight proportion of described Chinese medicine composition are following:
Cortex Cinnamomi 11.11%, Fructus Alpiniae Oxyphyllae 8.33%, the Radix Astragali 16.67%, Radix Salviae Miltiorrhizae 8.33%, Semen Persicae 8.33%, Semen Coicis 8.33%, Fructus Foeniculi 11.12%, the Radix Aucklandiae 8.33%, Fructus Toosendan 8.33%, Fructus Mume 11.12%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102181373A CN101966312B (en) | 2009-12-29 | 2009-12-29 | Chinese medicinal composition for treating chronic renal failure and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102181373A CN101966312B (en) | 2009-12-29 | 2009-12-29 | Chinese medicinal composition for treating chronic renal failure and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101966312A CN101966312A (en) | 2011-02-09 |
| CN101966312B true CN101966312B (en) | 2012-05-23 |
Family
ID=43545574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102181373A Expired - Fee Related CN101966312B (en) | 2009-12-29 | 2009-12-29 | Chinese medicinal composition for treating chronic renal failure and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101966312B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103007161B (en) * | 2013-01-16 | 2014-09-10 | 成都中医药大学 | External patch for treating nocturnal enuresis and preparation method thereof |
| CN103109879B (en) * | 2013-02-27 | 2014-11-26 | 绍兴文理学院元培学院 | Preparation method of torreya grandis aril essential oil clathrate compound |
| CN104288366A (en) * | 2014-10-10 | 2015-01-21 | 天津瑞贝特科技发展有限公司 | Liver and kidney protecting oral liquid for chickens and preparation method of liver and kidney protecting oral liquid |
| CN113812377B (en) * | 2021-09-07 | 2023-03-14 | 清源之光(武汉)生物科技有限公司 | Method for establishing burn and chronic kidney disease combined experimental model |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101584459A (en) * | 2008-05-20 | 2009-11-25 | 李彦奎 | Health tea for treating kidney disease yang deficiency |
-
2009
- 2009-12-29 CN CN2009102181373A patent/CN101966312B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101584459A (en) * | 2008-05-20 | 2009-11-25 | 李彦奎 | Health tea for treating kidney disease yang deficiency |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101966312A (en) | 2011-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101766777B (en) | Chinese medicine composite for treating chronic renal failure | |
| CN103638136B (en) | Cordyceps QISHEN CAPSULE | |
| CN102397372A (en) | Medicinal composition and pharmaceutical preparation and application thereof to treating irritable bowel syndrome | |
| CN101966312B (en) | Chinese medicinal composition for treating chronic renal failure and preparation method thereof | |
| CN101920002A (en) | Chinese medicinal formula for treating gout and hyperuricemia | |
| CN105853678A (en) | Traditional Chinese medicinal composition for treating membranous nephropathy and method for preparing traditional Chinese medicinal composition for treating membranous nephropathy | |
| CN103655599B (en) | Polysaccharide composition and application, containing its pharmaceutical preparation | |
| CN117482131A (en) | Traditional Chinese medicine composition for treating chronic kidney disease and application thereof | |
| CN103638135B (en) | Pure and impure kidney-tonifying capsule | |
| CN109078060B (en) | Traditional Chinese medicine preparation for treating chronic renal failure and preparation method thereof | |
| CN100453110C (en) | Chinese medicine preparation for treating mephritis and nephrosis syndrome | |
| CN104888157A (en) | Traditional Chinese medicine preparation for treating hysteromyoma and preparation method thereof | |
| CN101647985B (en) | Medicament composition for treating psoriasis | |
| CN101549075B (en) | Traditional Chinese medicine composition for treating mammary gland hyperplasia and preparation method thereof | |
| CN101317881A (en) | Traditional Chinese medicine compound and formulation for removing renal stone | |
| CN107519430A (en) | A kind of Chinese medicine composition for treating PBC and its preparation method and application | |
| CN100528186C (en) | Process for preparing Chinese medicine compound injection for treating chronic renal failure and use | |
| CN108634300B (en) | Health product with auxiliary blood sugar reducing function and preparation method thereof | |
| CN103191293B (en) | Sub-health-preventive drug composition and preparation method thereof | |
| CN106668431B (en) | A Chinese medicinal composition with effects of warming kidney and invigorating qi, and its preparation method and application | |
| CN103006891B (en) | Medicine composition for treating chronic renal failure | |
| CN107693593B (en) | Traditional Chinese medicine composition for preventing and treating coronary heart disease | |
| CN104352797A (en) | Traditional Chinese medicine for treating advanced lung cancer and application of traditional Chinese medicine | |
| CN104740345B (en) | Treat Chinese medicine composition of diabetes and preparation method thereof | |
| CN113855754B (en) | Traditional Chinese medicine composition for removing blood stasis and stopping bleeding as well as preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120523 Termination date: 20131229 |